http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102413831-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_132aa5ddba376cda52c2bedb26765245
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4985
filingDate 2010-04-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_88da8dbb8265e660ce1d5bec8c694a7f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_804db5259195e9e16233f3ac6dfc5416
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e4b11e6862e61e62ed1569da55dfe38b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_595216656696183d782c4908958f1bb4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_252492a1a013070e3a55740a4569d9c4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c6654b81e263904a16753f2c2a10962f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1beb761a2762e4bfa277ef6aa15f5d0d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0b7ee43be70efc9f290bc267ec6067d2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4c458ce2e850fec9fc30cd7d808d292c
publicationDate 2012-04-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-102413831-A
titleOfInvention Substituted imidazoquinoxalines
abstract The present invention relates to substituted imidazoquinoxaline compounds of general formula (I), which act as inhibitors of Mps-1 kinase or TTK, and have anti-inflammatory and anti-cancer activities.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110698418-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114621232-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114621232-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107454900-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109999036-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107454900-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114364679-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022166548-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114364679-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-RE49353-E
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021169958-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110698418-A
priorityDate 2009-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009043934-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID149355741
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414253971

Total number of triples: 44.